These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23748639)

  • 1. [Adjuvant chemotherapy for non-small cell lung carcinoma Stage IA p-T1N0M0. A changed "scenario" after the 2009 7th edition of TNM staging system].
    Salvati F; Combi G
    Recenti Prog Med; 2013 Apr; 104(4):159-62. PubMed ID: 23748639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of adjuvant chemotherapy in the treatment of early stage NSCLC after radical surgery].
    De Marinis F; De Petris L
    Suppl Tumori; 2004; 3(4):S50-1. PubMed ID: 15206212
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy for resected non-small cell lung cancer.
    Wakelee H; Chhatwani L
    Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant systemic therapy for stage I NSCLC.
    Vallières E
    Thorac Surg Clin; 2007 May; 17(2):279-85. PubMed ID: 17626406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors.
    Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):963-7. PubMed ID: 20951601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informing decisions concerning adjuvant chemotherapy following surgical resection for non-small cell lung cancer: a mathematical modelling study.
    Utley M; Paschalides C; Treasure T
    Lung Cancer; 2006 Aug; 53(2):153-6. PubMed ID: 16765477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment of early stage non-small-cell lung cancer.
    Wada H
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):102-5. PubMed ID: 10442375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toward the overcoming of controversies about adjuvant chemotherapy in patients radically resected for NSCLC stage IA].
    Salvati F
    Clin Ter; 2013; 164(4):291-2. PubMed ID: 24045509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations for surgical treatment of nonsmall cell lung cancer].
    Cordoş I; Bolca C; Paleru C
    Pneumologia; 2009; 58(2):135-40. PubMed ID: 19637769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 17. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
    Azzoli CG
    Nat Clin Pract Oncol; 2005 Nov; 2(11):552-3. PubMed ID: 16270095
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
    Berghmans T
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.